Navigation Links
Gaddi H. Vasquez Named Chairman of the PCI Board of Directors
Date:8/6/2014

San Diego, CA (PRWEB) August 06, 2014

In PCI’s annual meeting of the Board of Directors on August 2nd, Ambassador Gaddi H. Vasquez was elected Board Chairman of San Diego-based PCI (Project Concern International). Vasquez will spearhead the strategic direction of PCI’s efforts to expand its work to prevent disease and promote sustainable development in 16 countries around the globe.    

“Ambassador Vasquez is a recognized leader in both the global development and business communities, and we are thrilled to have him at the helm of PCI’s Board of Directors,” said PCI President & CEO George Guimaraes. “His background and expertise in leading efforts to combat global poverty will be a tremendous asset to PCI as we continue to grow and work to improve the lives of millions around the world.”

Vasquez served as the U.S. Ambassador and permanent representative to United Nations Agencies based in Rome from 2006 to 2009, working specifically with the World Food Program and the Food and Agriculture Organization. From 2002 to 2006, he was the Director of the U.S. Peace Corps, overseeing the agency’s programs in 78 countries. He is currently the senior vice president of Government Affairs for Southern California Edison and Edison International.

“PCI is an organization on the move! Its programs strike at the root causes of poverty and provide opportunities for people to improve their own lives,” said Ambassador Vasquez. “At a time when the world is in such disarray, PCI’s work is truly making a difference by transforming communities across the globe, and I am honored to be a part of their life-changing work.”    

PCI’s mission is to prevent disease, improve community health and promote sustainable development worldwide. Motivated by a concern for the world’s most vulnerable children, families and communities, PCI envisions a world where abundant resources are shared, communities are able to provide for the health and well-being of their members, and children and families can achieve lives of hope, good health and self-sufficiency.

To learn more about PCI’s work, visit http://www.PCIGlobal.org.

###

PCI (Project Concern International) is an international health, development and humanitarian assistance organization, operating in 16 countries worldwide. Funded by federal grants and private support, PCI is dedicated to saving lives and building healthy communities around the globe, benefiting over 5.8 million people annually in Asia, Africa and the Americas. PCI’s headquarters are located in San Diego, CA and the organization also has an office in Washington, DC and a Seattle, WA representative. PCI’s current annual budget is $49 million and the organization has nearly 600 employees worldwide.

Read the full story at http://www.prweb.com/releases/2014/08/prweb12074687.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Harry Race Pharmacy Named 2014 Good Neighbor Pharmacy of the Year
2. Ron Johnson Named Co-Lead Counsel in Lawsuits for Men Injured by AndroGel and Testosterone
3. Six Schools of Nursing Named National League for Nursing Centers of Excellence in Nursing Education for 2014-18
4. Max Solonski, Caesars Entertainment Claim Top Awards at ISE® West Ralph Johnson (King County, WA) named People’s Choice Award Winner
5. Loffler Companies Named Microsoft Community Connections Partner of the Year Award Winner
6. Care Communications, Inc. Named an Elite Award Winner Among Top Chicago Employers
7. FAMU Professor and Engineering Student Named Fulbright Scholars
8. Abington Health Website Named Best in Class
9. DynaMed™ Names Peter Oettgen, MD as Deputy Editor of Cardiology
10. Professional Healthcare at Home’s Karen Schulkin Named Top 10 Finalist Representing California for 2014 Home Care & Hospice Nurse of the Year
11. Four Allegheny Health Network Hospitals Named High Performers by U.S. News
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis of genetic variants ... points to eight genes that may explain why susceptibility to one of the disorders ... a study published today in the journal npj Schizophrenia. , “There is a ...
(Date:2/24/2017)... ... February 24, 2017 , ... In the Health Care IT ... top priority because it’s not if you will be attacked, but when.” However, he ... comes to digital health care. , Improvements in auditing and monitoring have taken security ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: ... ’s true account of his paramedic experiences. Schanssema describes the tragedies he saw, as ... attempts to overcome them. , Schanssema, initially unsure of the career path he wanted ...
(Date:2/24/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has ... Yisrayl makes an astounding statement when he says that the entire Bible was written ... the current times so plainly that anyone should be able to see the time ...
(Date:2/24/2017)... ... ... The Radiology Business Management Association will select the 2017 Quest ... Better Radiology Marketing Programs conference, held this year from March 5 to 7 ... given out in five categories. They are:, ,     Patient Marketing, a ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017  This ... US$ Thousand by the following Products: ... analyzed in the report include Pharmaceuticals, and Agrochemicals. The ... Japan , Europe , ... provided for the period 2015 through 2022. Also, a ...
(Date:2/24/2017)... , Feb. 23, 2017  The particle ... million by 2021 from USD 275.9 million in ... Read the full report: http://www.reportlinker.com/p04718602-summary/view-report.html ... spending on pharmaceutical R&D, and growth in manufacturing ... the market growth for particle counters. On the ...
(Date:2/24/2017)...  Xynomic Pharmaceuticals, Inc., an oncology drug research ... acquired exclusive worldwide rights to develop, manufacture and ... targeting hematological and solid tumors. To ... 2 clinical trials of Abexinostat in US, EU ... been completed, demonstrating that Abexinostat is clinically active ...
Breaking Medicine Technology: